In one trial 2 patients with familial amyotrophic lateral sclerosis (ALS) and mutations in the gene encoding superoxide dismutase 1 (SOD1) were treated with a single intrathecal infusion of an AAV vector encoding a microRNA targeting SOD1. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.